Vaccine

Evaxion announces closing of $10.8 million public offering

COPENHAGEN, Denmark, January 31, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™…

1 year ago

Bavarian Nordic – Completion of Share Buy-Back Program

COPENHAGEN, Denmark, January 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced…

1 year ago

Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million

Montreal, Quebec--(Newsfile Corp. - January 31, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the…

1 year ago

Pharmacy Increases Revenue 52% for Vaccine Delivery Using Workflow Services

Medical billing platform has streamlined patient encounters by automating claim submissions and resolving issues with payors, new case study shows…

1 year ago

VMX 2025: A Record-Breaking Celebration of Innovation, Education and Thought Leadership in Veterinary Medicine

Breakthroughs in veterinary medicine, immersive hands-on experiences and Academy Award-winning actor and director Kevin Costner headline the world's largest and…

1 year ago

Evaxion announces pricing of $10.8 million public offering

COPENHAGEN, Denmark, January 30, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™…

1 year ago

“Closing Care Gaps and Lowering Readmissions: The Grapefruit Health Advantage at New England Inpatient Specialists”

CHICAGO, Jan. 29, 2025 /PRNewswire/ -- Summary Grapefruit Health has successfully launched its partnership with New England Inpatient Specialists (NEIS),…

1 year ago

Potential Revolution in Healthcare Brewing, Powered by AI Innovation

USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 29, 2025 /PRNewswire/ -- USA News…

1 year ago

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan…

1 year ago

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer…

1 year ago